BioLife Solutions, Inc. (BLFS)
Oct 6, 2026 - BLFS was delisted (reason: acquired by RGEN)
38.61
+1.31 (3.51%)
Inactive · Last trade price on Oct 5, 2026
BioLife Solutions Revenue
BioLife Solutions had revenue of $28.47M in the quarter ending June 30, 2026, with 21.45% growth. This brings the company's total for the last twelve months to $102.82M. In the year 2025, BioLife Solutions had annual revenue of $96.21M with 28.89% growth.
Revenue (ttm)
$102.82M
Revenue Growth
+28.89%
P/S Ratio
17.70
Revenue / Employee
$688,310
Employees
155
Market Cap
1.89B
Revenue by Geography
- United States 76.97M 80.0%
- Europe, Middle East, Africa (EMEA) 13.47M 14.0%
- Other 5.77M 6.0%
Fiscal year ended Dec 31, 2025 See the full BioLife Solutions breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 96.21M | 21.57M | 28.89% |
| Dec 31, 2024 | 74.65M | 6.63M | 9.75% |
| Dec 31, 2023 | 68.02M | -8.22M | -10.79% |
| Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
| Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
| Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
| Dec 31, 2019 | 27.37M | 7.63M | 38.64% |
| Dec 31, 2018 | 19.74M | 8.72M | 79.11% |
| Dec 31, 2017 | 11.02M | 2.80M | 33.97% |
| Dec 31, 2016 | 8.23M | 1.78M | 27.57% |
| Dec 31, 2015 | 6.45M | 258.30K | 4.17% |
| Dec 31, 2014 | 6.19M | -2.76M | -30.83% |
| Dec 31, 2013 | 8.95M | 3.29M | 58.03% |
| Dec 31, 2012 | 5.66M | 2.90M | 105.28% |
| Dec 31, 2011 | 2.76M | 677.16K | 32.53% |
| Dec 31, 2010 | 2.08M | 499.97K | 31.61% |
| Dec 31, 2009 | 1.58M | 259.10K | 19.59% |
| Dec 31, 2008 | 1.32M | 350.24K | 36.02% |
| Dec 31, 2007 | 972.26K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
BLFS News
- 22 days ago - BioLife Solutions Transcript: EGM 2026 - Transcripts
- 27 days ago - BioLife Solutions Proxy statement: Proxy filing - Filings
- 6 weeks ago - BioLife Solutions Proxy statement: Proxy filing - Filings
- 7 weeks ago - BioLife Solutions Proxy statement: Proxy filing - Filings
- 2 months ago - BioLife Solutions Reports Second Quarter 2026 Financial Results - PRNewsWire
- 2 months ago - BioLife Solutions Earnings release: Q2 2026 - Filings
- 2 months ago - BioLife Solutions Quarterly report: Q2 2026 - Filings
- 3 months ago - BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal - GeekWire